sur NANOBIOTIX (EPA:NANO)
NANOBIOTIX to Release 2025 Financial Results and Update
Nanobiotix, a biotechnology company focusing on nanoparticle-based treatments for cancer and other major diseases, has announced the release of its financial results for Q4 and the full year of 2025. The results will be made public on March 31, 2026, post the close of the U.S. market. Following this, a conference call and webcast have been scheduled for April 1, 2026, at 8:00 AM EDT / 2:00 PM CEST, ahead of the U.S. market opening.
During the call, CEO Laurent Levy and CFO Bart van Rhijn will discuss the company's financial performance and business activities for 2025. Interested parties can access details through the webcast and conference call links available on the Nanobiotix website. They are encouraged to submit questions beforehand via email. A replay of the event will be archived online for those unable to attend live.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NANOBIOTIX